Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
12
2022
Industrial Hemp, Alicia Silverstone and The Office Bradley Arant Boult Cummings LLP
Jul
11
2022
No Rehearing Granted on California’s In-State Foie Gras Sales Ban Keller and Heckman LLP
Jul
11
2022
Medical Marijuana, Workers’ Compensation, and the CSA: Hazy Outlook for Employers As States Wrestle With Cannabis Reimbursement as a Reasonable Medical Expense Foley & Lardner LLP
Jul
8
2022
Waste Not Want Not: The Impact of EPA's Decision to Consider Reclassifying Discarded Polyvinyl Chloride as A Hazardous Waste K&L Gates
Jul
8
2022
JACK of All Trades? Not so Fast for This Brand Norris McLaughlin P.A.
Jul
8
2022
New Population-Based Option for the Maryland Primary Care Program in 2023 Sheppard, Mullin, Richter & Hampton LLP
Jul
8
2022
Ramesh “Sunny” Balwani, Former Theranos President and COO, Found Guilty on All Twelve Fraud Counts in High-Profile Trial ArentFox Schiff LLP
Jul
8
2022
France Restricts Labeling for Plant-Based Proteins Keller and Heckman LLP
Jul
7
2022
EPA Seeks Input from Small Businesses on Development of Proposed TSCA Data Reporting Rule Bergeson & Campbell, P.C.
Jul
7
2022
What’s Next in Washington? - July Edition Foley & Lardner LLP
Jul
7
2022
FDA Finalizes Guidance for Animal Food Facilities Keller and Heckman LLP
Jul
7
2022
EPA Announces New PFAS Health Advisory Levels, Releases Additional Funding for PFAS Remediation Womble Bond Dickinson (US) LLP
Jul
7
2022
Food Pesticide Residues — A Conversation with Sheryl Dolan and Meibao Zhuang, Ph.D [PODCAST] Bergeson & Campbell, P.C.
Jul
7
2022
Minnesota Legalizes the Consumption of THC Edibles—How Can Multistate Employers React to This Growing National Trend? Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jul
6
2022
Funding Oases for Biotechs: How Biotechnology Companies at All Stages Can Succeed Through Lean Times Foley & Lardner LLP
Jul
6
2022
California Governor Signs into Law Cannabis Tax Relief Bill Sheppard, Mullin, Richter & Hampton LLP
Jul
6
2022
Food Safety and Standards Authority of India Publishes New Regulations for Vegan Foods Keller and Heckman LLP
Jul
6
2022
Minnesota Inadvertently Allows Unregulated Intoxicating Cannabis Edible Products Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
5
2022
Current Trends in Legislation – June 2022 CMBG3 Law
Jul
5
2022
CMS Adopts Major Changes to LTC Facility Surveyor Guidance Sheppard, Mullin, Richter & Hampton LLP
Jul
5
2022
Recap of AHLA’s Annual Meeting Sheppard, Mullin, Richter & Hampton LLP
Jul
5
2022
PETA Petitions USDA-FSIS to Remove Animal Raising Claims from Label Approval Process Keller and Heckman LLP
Jul
1
2022
SCOTUS Raises the Bar for Proof of Intent Under the Controlled Substances Act ArentFox Schiff LLP
Jul
1
2022
FDA Webinar on Genome-Edited Animals for Food Use Keller and Heckman LLP
Jul
1
2022
Health Canada Issues Front-Of-Pack Labeling Regulation Keller and Heckman LLP
Jul
1
2022
Connecticut Update: Recreational Marijuana, Captive Audience Meetings, and Leave Notices Requirements Take Effect July 1, 20 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
30
2022
PBMs Continue to Draw Federal Scrutiny: PBM Transparency Act of 2022 Mintz
Jun
30
2022
Final Revision to HBCD Risk Determination Finds HBCD, as a Whole Chemical Substance, Presents an Unreasonable Risk Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins